IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
120M
Number of holders
65
Total 13F shares, excl. options
51.1M
Shares change
-4.9M
Total reported value, excl. options
$51.1M
Value change
-$5.07M
Put/Call ratio
0.38
Number of buys
29
Number of sells
-22
Price
$1.00

Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q4 2024

77 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q4 2024.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51.1M shares of 120M outstanding shares and own 42.45% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.9M shares), Avidity Partners Management LP (7.97M shares), Soleus Capital Management, L.P. (7.29M shares), RTW INVESTMENTS, LP (4.57M shares), VANGUARD GROUP INC (3.92M shares), JANUS HENDERSON GROUP PLC (2.69M shares), Focus Partners Wealth (2.17M shares), Omega Fund Management, LLC (1.79M shares), Ikarian Capital, LLC (1.61M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.